ADAR1 Capital Management »

Bhav Acquisition Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bhav Acquisition Corp shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bhav Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Bhav Acquisition Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bhav Acquisition Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.9M 495k 9.97

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Bhav Acquisition Corp

Jpmorgan Chase & Co
Meteora Capital
Polar Securities
Harraden Circle Investments
Magnetar Financial
ADAR1 Capital Management
Rivernorth Capital Management
Aristeia Capital
Toronto-Dominion Bank
Mizuho Securities Usa
DLD Asset Management
Saba Capital Management
Two Sigma Investments
Shaolin Capital Management
Boothbay Fund Management

View all funds holding Bhav Acquisition Corp